Inventiva(IVA)
搜索文档
Inventiva (IVA) Investor Presentation - Slideshow
2023-03-08 03:04
Developing innovative therapies in NASH Corporate Presentation March 2023 DISCLAIMERS This presentation contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in this presentation are forward-looking statements. These statements include, but are not limited to, forecasts, targets and estimates with respect to Inventiva’s pre-clinical programs and clinic ...
Inventiva (IVA) Investor Presentation - Slideshow
2022-06-13 17:22
inventiva | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-----------|-------|------------------------|-------|-------|------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | Developing innovative therapies in | | | | | NASH | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Corporate Presentation | | | | | | | | June 2022 | | | | | | | | | | | | | | | | | | | EURONEXT DISCLAIMER This presentation contains fo ...
Inventiva (IVA) Investor Presentation - Slideshow
2021-06-25 03:52
inventiva | --- | --- | --- | --- | --- | --- | --- | --- | |-----------|------------------------|-------|-------|------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | Developing innovative therapies in | | | | | | NASH and MPS | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Corporate Presentation | | | | | | | | June 2021 | | | | | | | | | | | | | | | | | DISCLAIMER This presentation contains forward-looking sta ...
Inventiva (IVEVF) Investor Presentation - Slideshow
2021-03-06 06:24
inventiva | --- | --- | --- | --- | --- | --- | --- | --- | |------------|------------------------|-------|-------|------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | Developing innovative therapies in | | | | | | NASH and MPS | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Corporate Presentation | | | | | | | | March 2021 | | | | | | | | | | | | | | | | | | | | | | | | | | DISCLAIMER This presentation contains ...